DHL is making a major push into the healthcare logistics sector with a $2.28 billion investment aimed at strengthening its position as a global leader in high-quality logistics solutions. The move is part of the company’s long-term strategy to offer comprehensive, integrated logistics services across the entire healthcare supply chain.
Announced on April 14, DHL’s investment plan spans through 2030 and allocates $1.13 billion to the Americas, $568 million to the Asia-Pacific region, and another $568 million to the Middle East and Africa.
Key focus areas include expanding global cold chain capabilities, establishing pharmaceutical logistics hubs, and developing sustainable packaging solutions. The company plans to offer consistent, end-to-end healthcare logistics services-covering storage, order fulfillment, and delivery-under a newly introduced brand, DHL Health Logistics.
The unified global operation is designed to streamline processes and accelerate service delivery worldwide. DHL’s growing focus on healthcare logistics is driven by rising demand for cell and gene therapies, as well as increasing rates of chronic illness, both of which point to strong market growth potential.
According to Research and Markets, the global healthcare logistics market is expected to reach $147 billion by 2029, up from $99.53 billion in 2024-an average annual growth rate of 10.4%.
Oscar de Bok, CEO of DHL Supply Chain, stated, “We are building a high-quality, integrated logistics system to ensure that essential medical supplies reach patients around the world on time.”
